Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-06-24

FDA Approved: RALDESY TM — Supplemental Application (Validus Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for RALDESY TM (trazodone hydrochloride oral) from Validus Pharmaceuticals LLC, indicating a supplemental/label change.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RALDESY (Trazodone hydrochloride)

Snippet

SUPPL AP for RALDESY TM (TRAZODONE HYDROCHLORIDE ORAL)